These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23306847)

  • 1. Sustained remission over 36 months of advanced hepatocellular carcinoma after short-term sorafenib therapy.
    Ahn SY; Lee HS; Kweon YO; Tak WY; Park SY
    Dig Dis Sci; 2013 May; 58(5):1428-32. PubMed ID: 23306847
    [No Abstract]   [Full Text] [Related]  

  • 2. A complete response induced by 21-day sorafenib therapy in a patient with advanced hepatocellular carcinoma.
    Hagihara A; Teranishi Y; Kawamura E; Fujii H; Iwai S; Morikawa H; Enomoto M; Tamori A; Kawada N
    Intern Med; 2013; 52(14):1589-92. PubMed ID: 23857091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current status and future perspective of sorafenib for advanced hepatocellular carcinoma].
    Ikeda M; Mitsunaga S; Shimizu S; Ohno I; Takahashi H; Okuyama H; Kuwahara A; Okusaka T
    Nihon Shokakibyo Gakkai Zasshi; 2012 Aug; 109(8):1346-54. PubMed ID: 22863957
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerability of single-agent sorafenib in the treatment of elderly patients with hepatocellular carcinoma (HCC).
    Francini E; Bianco V
    Hepatology; 2014 Aug; 60(2):764-5. PubMed ID: 25187926
    [No Abstract]   [Full Text] [Related]  

  • 5. Reproducible complete remission of advanced hepatocellular carcinoma with sorafenib in combination with clopidogrel.
    Tan-Shalaby JL
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25178887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abdominal aortic dissection during sorafenib therapy for hepatocellular carcinoma.
    Xu L; Wang B; Ding W
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):e24-e25. PubMed ID: 28163072
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy.
    Azmi AN; Chan WK; Goh KL
    J Dig Dis; 2015 Sep; 16(9):537-40. PubMed ID: 26147446
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma].
    Yamashita T; Kaneko S
    Nihon Shokakibyo Gakkai Zasshi; 2012 Aug; 109(8):1335-45. PubMed ID: 22863956
    [No Abstract]   [Full Text] [Related]  

  • 9. Complete and Sustained Off-Therapy Response to Sorafenib in Advanced Hepatocellular Carcinoma.
    Maida M; Macaluso FS; Valenza F; Virdone R
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):253-5. PubMed ID: 27308660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Response After Unusual Low Dose Sorafenib: Diagnosis with Perfusion CT and Follow-up in a Patient with Recurrent Hepatocellular Carcinoma.
    Sacco R; Faggioni L; Bargellini I; Romano A; Bertini M; Ginanni B; Battaglia V; Bertoni M; Bozzi E; Federici G; Metrangolo S; Parisi G; Neri E; Sodini E; Tumino E; Bresci G; Bartolozzi C
    J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S234-8. PubMed ID: 22752423
    [No Abstract]   [Full Text] [Related]  

  • 11. Sorafenib-associated psoriasiform eruption in a patient with hepatocellular carcinoma.
    İlknur T; Akarsu S; Çarsanbali S; Lebe B; Fetil E
    J Drugs Dermatol; 2014 Aug; 13(8):899-900. PubMed ID: 25116964
    [No Abstract]   [Full Text] [Related]  

  • 12. Sustained complete remission of metastatic hepatocellular carcinoma with single agent sorafenib.
    Lulla PD; Brammer JE; Bandeali S; Lynch GR
    J Gastrointest Cancer; 2013 Mar; 44(1):98-101. PubMed ID: 23054578
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
    Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
    Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Education and imaging. Hepatology: Complete regression of locally advanced hepatocellular carcinoma following Sorafenib monotherapy.
    Kumar S
    J Gastroenterol Hepatol; 2015 Mar; 30(3):438. PubMed ID: 25707790
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study.
    Cheng AL; Kang YK; He AR; Lim HY; Ryoo BY; Hung CH; Sheen IS; Izumi N; Austin T; Wang Q; Greenberg J; Shiratori S; Beckman RA; Kudo M;
    J Hepatol; 2015 Oct; 63(4):896-904. PubMed ID: 26071796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma.
    Takeyama H; Beppu T; Higashi T; Kaida T; Arima K; Taki K; Imai K; Nitta H; Hayashi H; Nakagawa S; Okabe H; Hashimoto D; Chikamoto A; Ishiko T; Tanaka M; Sasaki Y; Baba H
    Surg Today; 2018 Apr; 48(4):431-438. PubMed ID: 29110089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib-induced Acute Pancreatitis: A Case Report and Review of the Literature.
    Chou JW; Cheng KS; Huang CW
    Intern Med; 2016; 55(6):623-7. PubMed ID: 26984079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription Patterns of Sorafenib and Outcomes of Patients with Advanced Hepatocellular Carcinoma: A National Population Study.
    Lu LC; Chen PJ; Yeh YC; Hsu CH; Chen HM; Lai MS; Shao YY; Cheng AL
    Anticancer Res; 2017 May; 37(5):2593-2599. PubMed ID: 28476832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib combined with locoregional therapy prior to liver transplantation for hepatocellular carcinoma: an update on a previous case report.
    Vagefi PA; Hirose R
    J Gastrointest Cancer; 2013 Jun; 44(2):246-7. PubMed ID: 22815137
    [No Abstract]   [Full Text] [Related]  

  • 20. Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study.
    Nakano M; Tanaka M; Kuromatsu R; Nagamatsu H; Tajiri N; Satani M; Niizeki T; Aino H; Okamura S; Iwamoto H; Shimose S; Shirono T; Koga H; Torimura T;
    Cancer Med; 2015 Dec; 4(12):1836-43. PubMed ID: 26471348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.